Impact of automatic e-consults on use of SGLT2i and GLP-1 RA in rural veterans with type 2 diabetes and chronic kidney disease.
other
Where this comes from
- Record sourced from PubMed, PMID 41963153.
- Also identified by DOI 10.1016/j.pcd.2026.04.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this pilot study, we identified rural veterans with chronic kidney disease and type 2 diabetes who have an indication for SGLT2i or GLP-1 RA but not yet on either of these agents. Nearly a third of providers changed their practice based on automatic e-consult; however, there were still 69% of cases where providers did not.
Medical subject headings
- Diabetes Mellitus, Type 2
- Renal Insufficiency, Chronic
- Sodium-Glucose Transporter 2 Inhibitors
- Glucagon-Like Peptide-1 Receptor Agonists
- Incretins
- Veterans